Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-21
2006-11-21
Jones, Dwayne (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S649000, C514S264100, C514S266200, C514S304000, C514S307000, C514S317000, C514S415000, C514S646000
Reexamination Certificate
active
07138405
ABSTRACT:
Pharmaceutical combinations suitable for treating the lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in men are described herein. The combinations contain an alpha-adrenoceptor antagonist and a muscarinic antagonist that may be administered simultaneously, separately or sequentially. The methods of treatment using the combinations are particularly suitable for treating moderate or severe LUTS.
REFERENCES:
patent: 2503059 (1950-04-01), Miescher et al.
patent: 2599000 (1952-06-01), Kerwin et al.
patent: 3381009 (1968-04-01), Palazzo et al.
patent: 4252721 (1981-02-01), Silvestrini et al.
patent: 4703063 (1987-10-01), Imai et al.
patent: 5096890 (1992-03-01), Cross et al.
patent: 5233053 (1993-08-01), Cross et al.
patent: WO 9409785 (1994-05-01), None
patent: WO 9830560 (1998-07-01), None
patent: WO 0121167 (2001-03-01), None
Barry et al., J. Urol., vol. 148, pp. 1549-1557, (1992).
J.P. Hieble, et al., vol. 30, 1995, pp. 269S-298S, “Recent Progress in the Pharmacotherapy of Diseases of the Lower Urinary Tract”.
Journal of Urology, 1985, vol. 134, pp. 1291-1298.
Kenny, et al., Urol., vol. 44, pp. 52-57, (1997).
Serels, S., and Stein, M., Prospectice Study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women, Nuerourological Urodynamics, vol. 17(1), pp. 31-36, 1998 (Abstract).
Tohoku J. Exp. Med., 1993, 170, 251-260, Effects of Intravesically Adminstered Anticholinergics, and β-Adrenergic Stimulant and α-Adrenergic Blocker on Bladder Function in Unanestgetized Rats.
Wallis et al., Life Sci., vol. 64, pp. 395-401, (1999).
Jones Dwayne
Novartis International Pharmaceutical Ltd
Waibel Peter J.
Wilusz Edward J.
LandOfFree
Pharmaceutical combinations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical combinations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical combinations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3632577